Stock Market & Financial News
Arbutus Biopharma: Moderna Validates My IP Bull Case
Arbutus Biopharma is now much better capitalized after Moderna validated the value of its LNP patents. As for ABUS' in-house assets, I think Imdusiran has shown durable viral control. The main caveat is that it comes from combo therapies. Their balance sheet gives them a comfortable runway to pursue imdusiran's upcoming Phase 2b trial, which is yet another optionality vertical for the stock.
MRNA SBI Holdings and Solana Forge Strategic Alliance to Build Japan's Onchain Financial Market
SBI Holdings and Solana Foundation announced a strategic collaboration to build an onchain financial market from Japan through SBI R3 Japan. SBI R3 Japan is expected to adopt the planned trade name SBI Solana Global and support JPYSC, tokenized RWAs, cross-border settlement, institutional services and AI-agent payments.
Where Fundamental Analysis Meets the Chartists: The Launch of Defiance's RANK ETF
In my former career as a stock research analyst, a unique dynamic always signaled a high-conviction idea. While I sat there building out earnings models and reworking valuation assumptions, the technical analysts would look for relative strength or weakness.
RANK Reactor Restarts Add New Layer to Nuclear Renaissance
The U.S. nuclear sector is moving beyond discussions about preserving existing reactor capacity.
CEG 
SK Hynix Makes its US Debut: Which ETFs Offer Exposure?
Friday, July 10, may have been ordinary for those outside the investment community, but for folks engaged with the market, it marked an opportunity to gain exposure to the second most valuable company in South Korea. On Friday, SK Hynix (SKHY) became available to U.S. investors via the Nasdaq.
EWY 
Here Are Monday's Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John's International, Shopify, and More
Futures are trading lower as we get ready for the start of second-quarter earnings this week, after a solid winning week on Wall Street.
BIIB 
Butler National: The Multi-Year Aerospace Growth Story Is Just Beginning
Butler National Corporation maintains a strong buy rating, driven by robust aerospace growth and margin expansion. Recent muted share price performance reflects sector rotation, cost inflation risks, and delayed NASDAQ uplisting catalysts. FY26 sales grew 17% to $98M, with aerospace up 33% and operating margin expanding from 20% to 29%.
BUKS 
Morning Minute: BTC and ETH ETFs Flip Green After Lengthy Outflow Stretch
U.S. spot Bitcoin ETFs closed their first positive week since May, but a big week ahead will likely determine crypto's near-term fate.
Ripple Joins BlackRock and J.P. Morgan to Tokenize UK Debt Worth £33 Billion
The UK Treasury has officially brought Ripple into a large-scale government reform aimed at tokenizing wholesale financial markets. The technology giant has joined a special working group of 54 participants established under the auspices of Wholesale Digital Markets Champion Chris Woolard and the City of London Corporation.
Gold Price Forecast: XAU/USD drifts below $4,100, but bears start to look exhausted
Gold Price Forecast: XAU/USD drifts below $4,100, but bears start to look exhausted
Nike: Iconic Brand But Wouldn't Touch It With A 10-Foot Pole Right Now
Nike remains a hold as persistent margin pressure and tepid revenue growth offset its iconic brand and near-4% dividend yield. NKE's recent double-beat earnings were inflated by a $986M one-time tariff refund; underlying EPS and margins declined, raising concerns about sustainable profitability. North America showed resilience, but declines in EMEA, APLA, and Greater China, plus flat FY'27 revenue guidance, limit near-term upside potential.
NKE 
Hyperliquid's real-world asset markets hit record $4B open interest
Hyperliquid's growth in tokenized assets signals a shift towards decentralized finance, potentially reshaping traditional market dynamics. Hyperliquid's real-world asset markets hit record $4B open interest.
Bitcoin Dips on Monday Morning Shockwave; XRP Breaks Below Key $1.10 Level
Bitcoin fell from above $64,300 at the weekly close to around $63,100, briefly touching $62,400 before rebounding above $63,000 on Monday. Renewed U.S.-Iran hostilities, equity weakness and profit-taking hit sentiment, while XRP broke below $1.10 and ETH failed at $1,800.
Is Disney or PayPal the Better Rebound Play Now?
Walt Disney (NYSE:DIS | DIS Price Prediction) and PayPal (NASDAQ:PYPL) are both trading well below their multi-year highs, attracting income-oriented investors hunting for a rebound.
PYPL 
Diageo needs plausible and sustainable profit reset to rebuild confidence, says Deutsche Bank
Diageo PLC (LSE:DGE) faces growing pressure to reset investor expectations when it reports annual results next month, with Deutsche Bank arguing the drinks group needs a more realistic profit base before it can return to consistent growth. The bank maintained its 'buy' rating but cut its target price to 1,700p from 1,759p ahead of the company's results and strategy update on 6 August.
DEO 
UBS stays positive on AstraZeneca ahead of second-quarter results
UBS expects AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to report solid second-quarter results later this month, though it sees little room for the drugmaker to raise full-year guidance. The bank reiterated its 'buy' rating on Britain's second most valuable listed company, ahead of results due on 27 July.
UBS 
BNB Chain's AWS-Linked Agent Studio Pushes AI Back Into The Crypto Infrastructure Race
The AI-agent narrative in crypto has gone through plenty of hype, but BNB Chain is trying to move the discussion toward tooling. Its new Agent Studio roadmap, built around developer templates and AWS-linked infrastructur
Bitcoin whale moves $188M for first time in 7 years
A dormant whale transferred BTC worth $188 million after seven years of holding, adding to the growing ratio of whale transfers to cryptocurrency exchanges.
Ripple supports UK tokenization strategy, potential £33B boost by 2035
Ripple's support for UK tokenization could enhance digital asset adoption, positioning the UK as a leader in financial innovation. Ripple supports UK tokenization strategy, potential £33B boost by 2035.
3 U.S. politicians made super suspicious SpaceX stock bets just after historic IPO
Three members of the U.S. House of Representatives purchased SpaceX (NASDAQ: SPCX) shares within days of the company's record-breaking initial public offering (IPO).
SPCX 
Gjensidige Forsikring ASA (GJNSY) Q2 2026 Earnings Call Transcript
Gjensidige Forsikring ASA (GJNSY) Q2 2026 Earnings Call Transcript
GJNSY 
Solana price forms a falling wedge, can it break past $80 psychological resistance?
Solana price has remained below the $80 psychological barrier after renewed macro pressure and weakening risk appetite pushed buyers into a wait-and-see mode despite an emerging bullish chart pattern. According to data from crypto.news, Solana (SOL) price traded near $76.
This Is Why ASML Is a No-Brainer Buy Before July 15 Earnings
Own ASML Holding (NASDAQ:ASML | ASML Price Prediction) before the opening bell on July 15 when the company reports Q2 results and almost certainly reiterates a raised full-year outlook the market is still underpricing.
ASML 
ASML is kicking off tech earnings. Here's what to expect from Europe's biggest semiconductor supplier.
The Dutch semiconductor-equipment manufacturer is reporting its second-quarter results on Wednesday, with analysts expecting a 15% rise in earnings per share year-over-year.
ASML 
GBP/USD Price Forecast: Bounces back to near 1.3400 as US Dollar turns upside down
GBP/USD Price Forecast: Bounces back to near 1.3400 as US Dollar turns upside down
XRP Victory Day marks 3 years since Ripple's SEC lawsuit win
XRP Victory Day marks 3 years since Ripple's partial U.S. SEC win, while its $125 million penalty and institutional-sales injunction remain.
Eric Trump's American Bitcoin Bleeds $600M as Whales Wage a $107M Ethereum Duel
Crypto's appetite for high-stakes bets was on full display Monday as shares of Eric Trump's American Bitcoin collapsed 95% from their peak, erasing more than $600 million from his stake. Simultaneously, two traders squared off onchain with $107 million in opposing leveraged ether positions.
Should You Invest in the VanEck Biotech ETF (BBH)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on December 20, 2011.
BBH 
Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
Launched on June 16, 2006, the WisdomTree U.S. SmallCap Dividend ETF (DES) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Value segment of the US equity market.
DES 
Is Invesco S&P International Developed Quality ETF (IDHQ) a Strong ETF Right Now?
A smart beta exchange traded fund, the Invesco S&P International Developed Quality ETF (IDHQ) debuted on 06/13/2007, and offers broad exposure to the Foreign Large Growth ETF category of the market.
IDHQ 
